UA94211C2 - Isolated fully human monoclonal anti-cd3 antibody - Google Patents

Isolated fully human monoclonal anti-cd3 antibody

Info

Publication number
UA94211C2
UA94211C2 UAA200700106A UAA200700106A UA94211C2 UA 94211 C2 UA94211 C2 UA 94211C2 UA A200700106 A UAA200700106 A UA A200700106A UA A200700106 A UAA200700106 A UA A200700106A UA 94211 C2 UA94211 C2 UA 94211C2
Authority
UA
Ukraine
Prior art keywords
human monoclonal
fully human
antibody
monoclonal anti
isolated fully
Prior art date
Application number
UAA200700106A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Бернар Мах
Ян Дин
Мари Коско-Вильбуа
Грег Кристофер Эндрю Элсон
Николас Фишер
Оливье Леже
Original Assignee
Новиммюн С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новиммюн С.А. filed Critical Новиммюн С.А.
Publication of UA94211C2 publication Critical patent/UA94211C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to fully human monoclonal antibody directed to CD3 or immunologically active fragment thereof.
UAA200700106A 2004-06-03 2005-06-03 Isolated fully human monoclonal anti-cd3 antibody UA94211C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57648304P 2004-06-03 2004-06-03

Publications (1)

Publication Number Publication Date
UA94211C2 true UA94211C2 (en) 2011-04-26

Family

ID=38166712

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200700106A UA94211C2 (en) 2004-06-03 2005-06-03 Isolated fully human monoclonal anti-cd3 antibody

Country Status (3)

Country Link
CN (1) CN1984931B (en)
UA (1) UA94211C2 (en)
ZA (1) ZA200609891B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2647707T3 (en) * 2010-11-30 2019-02-28 Chugai Seiyaku Kabushiki Kaisha Cytotoxicity-inducing therapeutic agent
SG10201705787VA (en) * 2012-09-27 2017-08-30 Merus Nv BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS
CN111410691B (en) * 2014-03-28 2024-02-13 Xencor公司 Bispecific antibodies that bind to CD38 and CD3
HUE059417T2 (en) * 2014-11-24 2022-11-28 Regeneron Pharma Non-human animals expressing humanized cd3 complex
CN104558180B (en) * 2014-12-31 2017-11-03 四川大学 Target the human single chain variable fragments antibody of T lymphocytes
TWI726862B (en) * 2015-01-23 2021-05-11 法商賽諾菲公司 Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
SI3115376T1 (en) 2015-07-10 2018-12-31 Merus N.V. Human cd3 binding antibody
SG11202010580TA (en) * 2018-05-23 2020-12-30 Pfizer Antibodies specific for cd3 and uses thereof
CN115536740A (en) * 2021-06-30 2022-12-30 苏州方德门达新药开发有限公司 Space conformation epitope for effectively retaining CD3 in mediated cell and application thereof
WO2023169419A1 (en) * 2022-03-09 2023-09-14 Antengene (Hangzhou) Biologics Co., Ltd. Novel anti-cd3 antibodies and uses thereof
CN115850486B (en) * 2022-11-16 2023-05-30 艾可泰科(浙江)控股有限公司 Use of islet stem cells in the treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1169953C (en) * 1999-11-30 2004-10-06 中国医学科学院中国协和医科大学血液学研究所血液病医院 CD3-resisting single clone antibody heavy-chain and light-chain variable-area gene and its application
CN1189483C (en) * 2001-11-23 2005-02-16 上海中信国健药业有限公司 Humanized CD3-resisting monoclonal antibody

Also Published As

Publication number Publication date
CN1984931A (en) 2007-06-20
ZA200609891B (en) 2008-07-30
CN1984931B (en) 2012-11-28

Similar Documents

Publication Publication Date Title
UA94211C2 (en) Isolated fully human monoclonal anti-cd3 antibody
IL244803B (en) Humanized anti-beta7 antibodies and uses therefor
ZA200501054B (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use.
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
TW200639182A (en) Antibody variants and uses thereof
UA92505C2 (en) Anti-cd3 antibody formulations
IL179672A (en) Human monoclonal anti-cd3 antibodies
NZ605429A (en) Therapeutic human anti-il-1r1 monoclonal antibody
CY1111622T1 (en) ANTI-CMET HUMANIZED COMPETITORS
HK1098825A1 (en) Human monoclonal antibodies against cd20
TW200510459A (en) RG1 antibodies and uses thereof
HK1077226A1 (en) Human monoclonal antibodies against cd25
TW200603828A (en) Treatment of disorders
ITMI20031127A1 (en) ANTI-HGF-R ANTIBODIES AND THEIR USE
WO2006029220A3 (en) Combination therapy with anti-ctla4 and anti-4-1bb antibodies
UA98100C2 (en) Humanized monoclonal antibody that binds and neutralizes human nogo
UA96426C2 (en) Isolated human or humanized antibody that specifically binds to il-13